Modeling human hepatic steatosis in pluripotent stem cell-derived hepatocytes

Summary: This protocol describes the production of hepatocyte-like cells (HLCs) from human pluripotent stem cells and how to induce hepatic steatosis, a condition characterized by intracellular lipid accumulation. Following differentiation to an HLC phenotype, intracellular lipid accumulation is ind...

Full description

Bibliographic Details
Main Authors: Matthew C. Sinton, Jose Meseguer-Ripolles, Baltasar Lucendo-Villarin, Amanda J. Drake, David C. Hay
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:STAR Protocols
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666166721002008
id doaj-8d13b0dc3bd7402bb841e0635d89763b
record_format Article
spelling doaj-8d13b0dc3bd7402bb841e0635d89763b2021-06-21T04:25:24ZengElsevierSTAR Protocols2666-16672021-06-0122100493Modeling human hepatic steatosis in pluripotent stem cell-derived hepatocytesMatthew C. Sinton0Jose Meseguer-Ripolles1Baltasar Lucendo-Villarin2Amanda J. Drake3David C. Hay4University/BHF Centre for Cardiovascular Science, University of Edinburgh, The Queen's Medical Research Institute, Edinburgh BioQuarter, 47 Little France Crescent, Edinburgh EH16 4TJ, UK; Corresponding authorCentre for Regenerative Medicine, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh BioQuarter, 5 Little France Crescent, Edinburgh EH16 4UU, UKCentre for Regenerative Medicine, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh BioQuarter, 5 Little France Crescent, Edinburgh EH16 4UU, UKUniversity/BHF Centre for Cardiovascular Science, University of Edinburgh, The Queen's Medical Research Institute, Edinburgh BioQuarter, 47 Little France Crescent, Edinburgh EH16 4TJ, UKCentre for Regenerative Medicine, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh BioQuarter, 5 Little France Crescent, Edinburgh EH16 4UU, UK; Corresponding authorSummary: This protocol describes the production of hepatocyte-like cells (HLCs) from human pluripotent stem cells and how to induce hepatic steatosis, a condition characterized by intracellular lipid accumulation. Following differentiation to an HLC phenotype, intracellular lipid accumulation is induced with a steatosis induction cocktail, allowing the user to examine the cellular processes that underpin hepatic steatosis. Furthermore, the renewable nature of our system, on a defined genetic background, permits in-depth mechanistic analysis, which may facilitate therapeutic target identification in the future.For complete details on the use and execution of this protocol, please refer to Sinton et al. (2021).http://www.sciencedirect.com/science/article/pii/S2666166721002008Cell DifferentiationStem Cells
collection DOAJ
language English
format Article
sources DOAJ
author Matthew C. Sinton
Jose Meseguer-Ripolles
Baltasar Lucendo-Villarin
Amanda J. Drake
David C. Hay
spellingShingle Matthew C. Sinton
Jose Meseguer-Ripolles
Baltasar Lucendo-Villarin
Amanda J. Drake
David C. Hay
Modeling human hepatic steatosis in pluripotent stem cell-derived hepatocytes
STAR Protocols
Cell Differentiation
Stem Cells
author_facet Matthew C. Sinton
Jose Meseguer-Ripolles
Baltasar Lucendo-Villarin
Amanda J. Drake
David C. Hay
author_sort Matthew C. Sinton
title Modeling human hepatic steatosis in pluripotent stem cell-derived hepatocytes
title_short Modeling human hepatic steatosis in pluripotent stem cell-derived hepatocytes
title_full Modeling human hepatic steatosis in pluripotent stem cell-derived hepatocytes
title_fullStr Modeling human hepatic steatosis in pluripotent stem cell-derived hepatocytes
title_full_unstemmed Modeling human hepatic steatosis in pluripotent stem cell-derived hepatocytes
title_sort modeling human hepatic steatosis in pluripotent stem cell-derived hepatocytes
publisher Elsevier
series STAR Protocols
issn 2666-1667
publishDate 2021-06-01
description Summary: This protocol describes the production of hepatocyte-like cells (HLCs) from human pluripotent stem cells and how to induce hepatic steatosis, a condition characterized by intracellular lipid accumulation. Following differentiation to an HLC phenotype, intracellular lipid accumulation is induced with a steatosis induction cocktail, allowing the user to examine the cellular processes that underpin hepatic steatosis. Furthermore, the renewable nature of our system, on a defined genetic background, permits in-depth mechanistic analysis, which may facilitate therapeutic target identification in the future.For complete details on the use and execution of this protocol, please refer to Sinton et al. (2021).
topic Cell Differentiation
Stem Cells
url http://www.sciencedirect.com/science/article/pii/S2666166721002008
work_keys_str_mv AT matthewcsinton modelinghumanhepaticsteatosisinpluripotentstemcellderivedhepatocytes
AT josemeseguerripolles modelinghumanhepaticsteatosisinpluripotentstemcellderivedhepatocytes
AT baltasarlucendovillarin modelinghumanhepaticsteatosisinpluripotentstemcellderivedhepatocytes
AT amandajdrake modelinghumanhepaticsteatosisinpluripotentstemcellderivedhepatocytes
AT davidchay modelinghumanhepaticsteatosisinpluripotentstemcellderivedhepatocytes
_version_ 1721369014641360896